Review: Advances in the Pathogenesis and Treatment of Immune Thrombocytopenia Associated with Viral Hepatitis
- PMID: 37635907
- PMCID: PMC10449570
- DOI: 10.1055/s-0043-1772771
Review: Advances in the Pathogenesis and Treatment of Immune Thrombocytopenia Associated with Viral Hepatitis
Abstract
Hepatitis B virus and hepatitis C virus are the hepatitis subtypes that most commonly induce immune thrombocytopenia (ITP). Although the pathogenesis of viral hepatitis-associated ITP remains unclear, it may involve antibody cross-reactivity due to molecular mimicry, the formation of virus-platelet immune complexes, and T cell-mediated suppression of bone marrow hematopoiesis. Moreover, there is significant correlation between platelet count and the severity of viral hepatitis, the risk of progression to liver cirrhosis, and clinical prognosis. However, treatment of viral hepatitis-associated ITP is hindered by some antiviral drugs. In this review, we summarize research progress to date on the pathogenesis and treatment of viral hepatitis-related ITP, hoping to provide a reference for clinical diagnosis and treatment.
Keywords: immune thrombocytopenia; pathogenesis; treatment; viral hepatitis.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ).
Conflict of interest statement
Conflict of Interest None declared.
Similar articles
-
Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia.Blood. 2009 Apr 23;113(17):4086-93. doi: 10.1182/blood-2008-09-181073. Epub 2008 Nov 20. Blood. 2009. PMID: 19023115 Free PMC article.
-
Differentiation of autoimmune thrombocytopenia from thrombocytopenia associated with immune complex disease: systemic lupus erythematosus, hepatitis-cirrhosis, and HIV-1 infection by platelet and serum immunological measurements.Br J Haematol. 1999 Jun;105(4):1086-91. doi: 10.1046/j.1365-2141.1999.01469.x. Br J Haematol. 1999. PMID: 10554825
-
Introduction of direct-acting antiviral agents alters frequencies of anti-GPIIb/IIIa antibody-producing B cells in chronic hepatitis C patients with thrombocytopenia.Platelets. 2023 Dec;34(1):2161498. doi: 10.1080/09537104.2022.2161498. Platelets. 2023. PMID: 36597279
-
Other immune thrombocytopenias.Semin Hematol. 2007 Oct;44(4 Suppl 5):S24-34. doi: 10.1053/j.seminhematol.2007.11.004. Semin Hematol. 2007. PMID: 18096469 Review.
-
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP).J Clin Med. 2017 Feb 9;6(2):16. doi: 10.3390/jcm6020016. J Clin Med. 2017. PMID: 28208757 Free PMC article. Review.
References
-
- Rajan S K, Espina B M, Liebman H A. Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura. Br J Haematol. 2005;129(06):818–824. - PubMed
-
- Hajarizadeh B, Grebely J, Dore G J. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013;10(09):553–562. - PubMed
-
- Tejima K, Masuzaki R, Ikeda H et al.Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly. J Gastroenterol. 2010;45(08):876–884. - PubMed
Publication types
LinkOut - more resources
Full Text Sources